Your browser doesn't support javascript.
loading
Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Kayser, Sabine; Martínez-Cuadrón, David; Rodriguez-Veiga, Rebeca; Hänel, Mathias; Tormo, Mar; Schäfer-Eckart, Kerstin; Botella, Carmen; Stölzel, Friedrich; Del Castillo, Teresa Bernal; Keller, Ulrich; Rodriguez-Medina, Carlos; Held, Gerhard; Amigo, Maria-Luz; Schliemann, Christoph; Colorado, Mercedes; Kaufmann, Martin; Garcia, Manuel Barrios; Krause, Stefan W; Görner, Martin; Jost, Edgar; Steffen, Björn; Zukunft, Sven; Platzbecker, Uwe; Ho, Anthony D; Baldus, Claudia D; Serve, Hubert; Müller-Tidow, Carsten; Thiede, Christian; Bornhäuser, Martin; Montesinos, Pau; Röllig, Christoph; Schlenk, Richard F.
Afiliación
  • Kayser S; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, Mannheim, Germany; NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany; Medical Clini
  • Martínez-Cuadrón D; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain; CIBERONC, Instituto Carlos III, Madrid.
  • Rodriguez-Veiga R; Hematology Department, Hospital Universitari i Politècnic, La Fe, València.
  • Hänel M; Klinikum Chemnitz, Chemnitz.
  • Tormo M; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia.
  • Schäfer-Eckart K; Hospital Nord, Nurnberg.
  • Botella C; Hospital General, Alicante.
  • Stölzel F; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden.
  • Del Castillo TB; Hospital Central de Asturias.
  • Keller U; Department of Hematology, Oncology and Cancer Immunology, Charité-University Medical Center, Campus Benjamin Franklin, Berlin.
  • Rodriguez-Medina C; Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria.
  • Held G; Westpfalz Klinikum, Kaiserslautern.
  • Amigo ML; Hospital General Universitario Morales Meseguer, Murcia.
  • Schliemann C; University Hospital Muenster, Muenster.
  • Colorado M; Hospital Universitario Marqués de Valdecilla, Santander.
  • Kaufmann M; Robert Bosch Hospital Stuttgart, Stuttgart.
  • Garcia MB; Department of Hematology, Hospital Regional Universitario de Málaga, Málaga.
  • Krause SW; Department of Internal Medicine 5 - Hematology/Oncology, University Hospital of Erlangen, Erlangen.
  • Görner M; Klinik für Hämatologie, Onkologie und Palliativmedizin, Klinikum Bielefeld Mitte.
  • Jost E; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, University Hospital RWTH Aachen, Aachen.
  • Steffen B; Department of Internal Medicine II, University Hospital of Frankfurt Main.
  • Zukunft S; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden.
  • Platzbecker U; Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig.
  • Ho AD; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg.
  • Baldus CD; Department of Internal Medicine II, University Hospital of Kiel, Kiel Germany.
  • Serve H; Department of Internal Medicine II, University Hospital of Frankfurt Main.
  • Müller-Tidow C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg.
  • Thiede C; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden.
  • Bornhäuser M; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden.
  • Montesinos P; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain; CIBERONC, Instituto Carlos III, Madrid.
  • Röllig C; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden.
  • Schlenk RF; NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hosp
Haematologica ; 108(8): 2059-2066, 2023 08 01.
Article en En | MEDLINE | ID: mdl-36815361
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Child / Humans / Middle aged Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Child / Humans / Middle aged Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article